Evaluation of Psoriasis Area and Severity Index as a Proxy for Biomarkers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles

The efficacy of psoriasis treatments is usually evaluated using the Psoriasis Area and Severity Index (PASI). However, there is a lack of systematic statistical assessments of PASI as a proxy for systemic disease in individual patients. Therefore, a retrospective study of 186 treatments with adalimu...

Descripción completa

Detalles Bibliográficos
Autores principales: HOFFMANN, Jochen H. O., KNOOP, Chriatian, SCHÄKEL, Knut, ENK, Alexander H., HADASCHIK, Eva N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2021
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367049/
https://www.ncbi.nlm.nih.gov/pubmed/33903917
http://dx.doi.org/10.2340/00015555-3814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367049/
https://www.ncbi.nlm.nih.gov/pubmed/33903917
http://dx.doi.org/10.2340/00015555-3814

Ejemplares similares